ArticleBritish journal of cancer2012

Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models.

P Oliva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.